UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Aramark
ARMK
$14.7B
| $5.77M | ﹤0.01% |
169,679
+7,971
| +5% | +$259K |
|
2727
CALL
BHP
BHP
$230B
| $5.77M | ﹤0.01% |
101,040
-102,340
| -50% | -$5.95M |
|
2728
CALL
T. Rowe Price
TROW
$24.3B
| $5.77M | ﹤0.01% |
50,000
| – | – |
|
|
2729
PUT
T. Rowe Price
TROW
$24.3B
| $5.77M | ﹤0.01% |
50,000
| – | – |
|
2730
JPMorgan BetaBuilders Japan ETF
BBJP
$18.8B
| $5.76M | ﹤0.01% |
101,988
+4,469
| +5% | +$251K |
|
2731
Nuveen ESG Emerging Markets Equity ETF
NUEM
$384M
| $5.75M | ﹤0.01% |
200,725
-31,176
| -13% | -$872K |
|
2732
American Century Focused Large Cap Value ETF
FLV
$375M
| $5.75M | ﹤0.01% |
91,912
-115
| -0.1% | -$7.33K |
|
|
VZIO
2733
DELISTED
VIZIO Holding Corp.
VZIO
| $5.74M | ﹤0.01% |
531,547
-187,920
| -26% | -$2.01M |
|
2734
Crescent Energy
CRGY
$3.82B
| $5.74M | ﹤0.01% |
484,114
+325,223
| +205% | +$3.83M |
|
2735
New York Times
NYT
$10.2B
| $5.73M | ﹤0.01% |
111,883
+43,954
| +65% | +$2.07M |
|
|
AMED
2736
DELISTED
Amedisys
AMED
| $5.72M | ﹤0.01% |
62,337
-12,745
| -17% | -$1.18M |
|
2737
Invesco MSCI Sustainable Future ETF
ERTH
$138M
| $5.72M | ﹤0.01% |
144,995
+6,307
| +5% | +$260K |
|
2738
Intellia Therapeutics
NTLA
$1.67B
| $5.72M | ﹤0.01% |
255,551
-76,035
| -23% | -$1.81M |
|
2739
State Street SPDR S&P Bank ETF
KBE
$1.66B
| $5.72M | ﹤0.01% |
123,246
-208,143
| -63% | -$9.48M |
|
2740
PUT
Royal Caribbean
RCL
$85.6B
| $5.71M | ﹤0.01% |
35,800
-67,400
| -65% | -$9.69M |
|
2741
Cohen & Steers Quality Income Realty Fund
RQI
$1.69B
| $5.7M | ﹤0.01% |
488,289
+9,312
| +2% | +$106K |
|
2742
Vital Farms
VITL
$525M
| $5.7M | ﹤0.01% |
121,912
+56,081
| +85% | +$1.93M |
|
2743
Lazard
LAZ
$4.31B
| $5.7M | ﹤0.01% |
149,253
-52,168
| -26% | -$2.04M |
|
2744
PUT
BioNTech
BNTX
$23.5B
| $5.7M | ﹤0.01% |
70,900
+32,600
| +85% | +$2.98M |
|
2745
OneSpaWorld
OSW
$2.66B
| $5.7M | ﹤0.01% |
370,605
-35,524
| -9% | -$507K |
|
2746
Cullen/Frost Bankers
CFR
$10.2B
| $5.68M | ﹤0.01% |
55,936
-62,757
| -53% | -$6.57M |
|
2747
CALL
Nutanix
NTNX
$16.9B
| $5.68M | ﹤0.01% |
+99,900
| New | +$6.13M |
|
2748
PUT
SL Green Realty
SLG
$3.99B
| $5.66M | ﹤0.01% |
+100,000
| New | +$5.27M |
|
|
GTM
2749
ZoomInfo Technologies
GTM
$1.22B
| $5.66M | ﹤0.01% |
443,527
+53,671
| +14% | +$751K |
|
2750
Levi Strauss
LEVI
$9.39B
| $5.66M | ﹤0.01% |
293,567
-55,018
| -16% | -$1.21M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.